150 related articles for article (PubMed ID: 19295230)
1. [Favourable course of persisting malignant ascites].
Stange R; Jänsch A; Schrag S; Pflugbeil C; Schlodder D; Pandey-Hoffmann U; Uehleke B
Forsch Komplementmed; 2009 Feb; 16(1):49-53. PubMed ID: 19295230
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of NK cell activity against autologous tumour cells and K562 cells with the clinical outcome during therapy with mistletoe extracts].
Schink M; Tröger W; Goyert A; Scheuerecker H; Selbmann HK; Glaser F
Forsch Komplementmed; 2006 Jun; 13(3):147-55. PubMed ID: 16868360
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract.
Eisenbraun J; Scheer R; Kröz M; Schad F; Huber R
Phytomedicine; 2011 Jan; 18(2-3):151-7. PubMed ID: 20724129
[TBL] [Abstract][Full Text] [Related]
4. [Mistletoe in cancer treatment].
Umbreit D
Dtsch Med Wochenschr; 2011 Apr; 136 Suppl 1():S13-5. PubMed ID: 21452100
[No Abstract] [Full Text] [Related]
5. Preclinical and clinical effects of mistletoe against breast cancer.
Marvibaigi M; Supriyanto E; Amini N; Abdul Majid FA; Jaganathan SK
Biomed Res Int; 2014; 2014():785479. PubMed ID: 25136622
[TBL] [Abstract][Full Text] [Related]
6. [Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer].
Gerhard I; Abel U; Loewe-Mesch A; Huppmann S; Kuehn JJ
Forsch Komplementarmed Klass Naturheilkd; 2004 Jun; 11(3):150-7. PubMed ID: 15249749
[TBL] [Abstract][Full Text] [Related]
7. [Mistletoe therapy. An alternative cancer treatment].
Ernst E
MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
[No Abstract] [Full Text] [Related]
8. Demonstration of antibodies to the chitin-binding mistletoe lectin (cbML) in tumor patients before and during therapy with an aqueous mistletoe extract.
Klein R; Franz M; Wacker R; Classen K; Scheer R; Von Laue HB; Stoeva S; Voelter W
Eur J Med Res; 2004 Jun; 9(6):316-22. PubMed ID: 15257874
[TBL] [Abstract][Full Text] [Related]
9. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
[TBL] [Abstract][Full Text] [Related]
10. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
Pelzer F; Tröger W; Nat DR
J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
[TBL] [Abstract][Full Text] [Related]
11. Mistletoe and cancer: controversies and perspectives.
Mansky PJ
Semin Oncol; 2002 Dec; 29(6):589-94. PubMed ID: 12516042
[TBL] [Abstract][Full Text] [Related]
12. [Lectin compared to mistletoe use: experimental therapy form with preclinically verified risk potential].
Kuehn JJ; Kovacs E
Dtsch Med Wochenschr; 2002 Dec; 127(49):2637; author reply 2638. PubMed ID: 12469281
[No Abstract] [Full Text] [Related]
13. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
Ozols RF
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
[TBL] [Abstract][Full Text] [Related]
14. Randomized and double-blind studies--demands and reality as demonstrated by two examples of mistletoe research.
Rostock M; Huber R
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():18-22. PubMed ID: 15353898
[TBL] [Abstract][Full Text] [Related]
15. [Value of mistletoe therapy in carcinoma patients].
Rostock M; Unger C
Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
[No Abstract] [Full Text] [Related]
16. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
[TBL] [Abstract][Full Text] [Related]
17. The case for mistletoe in the treatment of laryngeal cancer.
Shakeel M; Trinidade A; Geider S; Ah-See KW
J Laryngol Otol; 2014 Mar; 128(3):302-6. PubMed ID: 24548675
[TBL] [Abstract][Full Text] [Related]
18. [Rapidly progressive ascites].
Hadengue A; Grosjean P; Genton C; Zwahlen A; Rieder P; Nicod P
Schweiz Med Wochenschr; 1996 Nov; 126(44):1891-7. PubMed ID: 8984602
[TBL] [Abstract][Full Text] [Related]
19. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts.
Kienle GS; Kiene H
Eur J Med Res; 2007 Mar; 12(3):103-19. PubMed ID: 17507307
[TBL] [Abstract][Full Text] [Related]
20. [Modification of mistletoe therapy to prevent epithelial tumors?].
Gabius HJ
Dtsch Med Wochenschr; 2001 Dec; 126(49):1415-6. PubMed ID: 11740638
[No Abstract] [Full Text] [Related]
[Next] [New Search]